Science Explorer Back to mapMap
Discussion
Researcher · Ospedale Maggiore · Italy

Stefano Angelini

Stefano Angelini publishes mostly in Hematology, Oncology and Molecular Biology, on topics such as Hematopoietic Stem Cell Transplantation, Chronic Lymphocytic Leukemia Research and Multiple Myeloma Research and Treatments.

ORCID 0000-0001-6720-3564 OpenAlex
World rank
#4,218,742
of 7,710,434 ranked researchers
Rank in Italy
#142,925
of 242,206
Works
36
Citations
571
Citations per work
15.9
h-index
12
i10-index 12Top 49% in Hematology
Stefano Angelini

What does Stefano Angelini research?

Stefano Angelini's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (16%), Social Sciences (6%).

Health Sciences: 14 works · 40.1% of their workMedicine: 14 works · 40.1% of their workHematology: 6 works · 16.8% of their workOncology: 5 works · 14.0% of their workGenetics: 3 works · 9.3% of their workEverything else: 14 works · 37.5% of their workLife Sciences: 6 works · 15.9% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 15.9% of their workMolecular Biology: 4 works · 11.2% of their workCancer Research: 2 works · 4.7% of their workSocial Sciences: 2 works · 6.5% of their workSocial Sciences: 2 works · 6.5% of their workSociology and Political Science: 2 works · 6.5% of their workTHEIR WORKStefano Angelini36works
Life Sciences16%Health Sciences40%Social Sciences6%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1440.1%
  2. Everything else1437.5%
    1. Biochemistry, Genetics and Molecular Biology615.9%
    1. Social Sciences26.5%
  1. 1Hematology17% of their works
  2. 2Oncology14% of their works
  3. 3Molecular Biology11% of their works
  4. 4Genetics9% of their works
  5. 5Sociology and Political Science6% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Stefano Angelini's research?

The keywords of their largest research topics: Rituximab, Bone Marrow Niche, Hematopoietic Stem Cells, PET Imaging, Chronic Lymphocytic Leukemia, Diagnosis Criteria, Genomic Aberrations and Immunosuppression.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab102 topics
  2. Bone Marrow Niche71 topic
  3. Hematopoietic Stem Cells71 topic
  4. PET Imaging72 topics
  5. Chronic Lymphocytic Leukemia61 topic
  6. Diagnosis Criteria61 topic
  7. Genomic Aberrations61 topic
  8. Immunosuppression62 topics
  9. International Myeloma Working Group61 topic
  10. Classification41 topic
  11. Lymphoma41 topic
  12. BET Bromodomains31 topic
  13. Fibroblast Activation Protein31 topic
  14. Merkel Cell Carcinoma31 topic
  15. PROTACs31 topic
  16. Polyomavirus31 topic
  17. Sickle-cell Disease31 topic
  18. Thalassemia31 topic
  19. Tumor Microenvironment31 topic

Where does Stefano Angelini work?

Stefano Angelini's main affiliation in the publication record is Ospedale Maggiore, Italy.

How many publications and citations does Stefano Angelini have?

OpenAlex counts 36 works and 571 citations for Stefano Angelini, an h-index of 12, ranking #4,218,742 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stefano Angelini. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.